Foghorn Therapeutics (FHTX) Price to Sales (2020 - 2026)
Powered by 
Analysis
Foghorn Therapeutics (FHTX) Price to Sales (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn |
| 10 | Foghorn Therapeutics | 346.08 Mn | 278.00 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.83 |
| Mar 31, 2026 | 85.90 |
| Dec 31, 2025 | 33.09 |
| Sep 30, 2025 | 33.91 |
| Jun 30, 2025 | 34.71 |
| Mar 31, 2025 | 34.17 |
| Dec 31, 2024 | 91.88 |
| Sep 30, 2024 | 66.29 |
| Jun 30, 2024 | 46.19 |
| Mar 31, 2024 | 56.58 |
| Dec 31, 2023 | 47.27 |
| Sep 30, 2023 | 12.08 |
| Jun 30, 2023 | 52.62 |
| Mar 31, 2023 | 48.84 |
| Dec 31, 2022 | 63.74 |
| Sep 30, 2022 | 54.06 |
| Jun 30, 2022 | 126.09 |
| Mar 31, 2022 | 160.96 |
| Dec 31, 2021 | 1,324.72 |
| Sep 30, 2021 | 12,586.18 |